KB

Kenneth J. Barr

Merck: 8 patents #20 of 1,208Top 2%
LY Lycera: 4 patents #3 of 26Top 15%
Overall (2017): #11,472 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Corey E. Bienstock +6 more 2017-10-10
9745265 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more 2017-08-29
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony, Matthew H. Daniels +2 more 2017-05-30
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Corey E. Bienstock +9 more 2017-05-30
9657033 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Thomas D. Aicher, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2017-05-23
9603838 RORgammaT inhibitors Willem Frederik Johan Karstens, Mario Van Der Stelt, Jos Cals, Rita Corte Real Goncalves Azevedo, Hongjun Zhang +3 more 2017-03-28
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-01-31